XT
CMPX icon

XTX Topco’s Compass Therapeutics CMPX Stock Holding History

XTX Topco’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$476K Buy
217,485
+147,364
+210% +$435K 0.01% 2506
2026
Q1 		$371K Sell
70,121
-45,513
-39% -$263K 0.01% 2294
2025
Q4 		$621K Buy
115,634
+98,684
+582% +$456K 0.02% 1408
2025
Q3 		$59.3K Sell
16,950
-15,465
-48% -$48.8K ﹤0.01% 2139
2025
Q2 		$84.3K Buy
+32,415
New +$66.8K ﹤0.01% 1915
2025
Q1 		– Sell
-52,754
Closed -$76.5K – 2499
2024
Q4 		$76.5K Buy
52,754
+32,533
+161% +$54K 0.01% 1820
2024
Q3 		$37.2K Buy
+20,221
New +$25.2K ﹤0.01% 1740
2023
Q3 		– Sell
-10,992
Closed -$35K – 1613
2023
Q2 		$35K Buy
+10,992
New +$34.5K 0.01% 1284

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

XTX Topco's CMPX Position: Q2 2026 in Review

XTX Topco increased its Compass Therapeutics (CMPX) stake by 210% in Q2 2026, buying an estimated $435K and bringing the position to 217,485 shares worth $476K. The position accounts for 0.01% of the portfolio, ranked #2506.

XTX Topco first reported a position in CMPX in Q2 2023 and has held it in 8 quarters since. The position peaked at $621K in Q4 2025. 215 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • XTX Topco held 217,485 shares of Compass Therapeutics worth $476K as of Q2 2026.
  • XTX Topco bought 147,364 Compass Therapeutics shares in Q2 2026, an estimated $435K.
  • Compass Therapeutics made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2506 holding.
  • XTX Topco first reported a position in Compass Therapeutics in Q2 2023 and has held it in 8 quarters since.
  • XTX Topco's Compass Therapeutics position peaked at $621K in Q4 2025.
  • 215 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.